This presentation provides an overview of Sun Pharmaceutical Industries Ltd. It discusses the company's profile, global ranking, objectives of the presentation which includes a SWOT analysis and understanding of the company's planning strategies, organizational structure, control mechanisms, and leadership style. It also examines the strategies implemented by Sun Pharma to be considered a best place to work. The presentation concludes with recommendations on how Sun Pharma can address weaknesses and extend its global market reach.
4. COMPANY PROFILE
Company Name Sun Pharmaceutical Industries Ltd.
Country/Territor
y
India
Business Type Pharmaceutical
Products/Service
Manufactures both Pharmaceutical and Active
Pharmaceutical Ingredients (API)
Industry Focus Therapeutic areas including
psychiatry,neorology,cardiology,diabetology,g
astroentology,respiratory and orthopaedics
Geographical
Market
World wide
Year Established 1983
Founder Dilip Shanghvi
6. OBJECTIVE OF THE
PRESENTATION-
•SWOT analysis of Sun
Pharmaceutical Industries Ltd.
•Understanding of – planning
strategies, organisation
structure, control and leadership
style of the company.
•Various strategies implemented
in order to get listed in the list
of best place to work at.
7.
8. SWOT ANALYSIS •Expertise in relatively
complex generic
pharmaceuticals
•Low cost generic
portfolio
•Successful acquisitions
over years
•Strong brand presence
in India and US
•Strong marketing and
sales force
Strength
9. SWOT ANALYSIS
Drug Price Control
order puts undue
pressure on product
prices, affecting the
profitability of the
pharmaceutical
companies.
Strick govt.
regulation & policies
afeect operational
efficiency
Office politics & too
Weakness
10. SWOT ANALYSIS
•Increase healthcare
awareness in urban
and rural India
•Enhance product
basket and market
presence
•Further acquisitions
will help in tapping
the emerging
global market
Opportunities
11. SWOT ANALYSIS •Stiff competition in generic
markets from other low cost
rivals like Cipla , Lupin,
Dr. Reddy’s Lab
•The company being more into
acquisition based growth might
lead to a stage of financial
crunch as it has already
happened in the case of Caraco
pharma where it provided debt
to Caraco and is facing
problems due to the continuous
losses made by the latter.
•Stringent patent regulations
Threats
12. PLANNING
STRATEGIES
Mission- Good
health and happiness
for all.
Vision- With good
health to all as a
primary objective,
Sun Pharmacy started
with an aims to be
among top 10
Generic pharmacies
and OTC player in
India with the help of
strategic growth and
stringent quality
measures.
14. ORGANISATION STRUCTURE
SUN PHARMA FOLLOWS A FUNCTIONAL UNITARY
STRUCTURE
Structured around a CEO and limited
corporate staff
Activities are grouped together by
common function
Each functional unit has different set of
duties and responsibilities
Specialisation is built into the
organisational structure
15. ORGANISATION STRUCTURE
Various organising teams are-
An wide range of specialists and world
class doctors
Financial audit team
Operation team
The R & D centres are supported by
around 2000 scientists and cutting edge
technologies
18. DETAILS OF MERGER
In April 2014 the Sun
Pharma took over Ranbaxy
The deal was set at US 4.2
billion approx.
The merger will help Sun
Pharma to enhance its
presence in emerging
pharma markets like
Russia, Brazil, South Africa
and also for better brand
building.
19. CONTROL MECHANISM
The company has a well
established internal control
framework
Global audit team function
carries out risk focused
audits across all
business(both India and
Global)
Operational management
team closely monitors
internal environment &
ensures that the
recommendations are
effectively implemented
Evaluation of performance
of the board, its committee
and every individual
directors are also done.
20. LEADERSHIP STYLE
Dilip Shanghvi , founder and
Managing Director Sun Pharma,
along with his team of CEOs,
presidents, vice-presidents and
other senior officials of the
merged entity shoulder
responsibilities to take the
company to the next level.
Sr. Officials maintain a cordial
relationship among each other
and also with their sub-ordinates
in order to reach quick decisions.
The MD engaged several world
class managers to head his
overseas venture in order to
build strong management
capabilities .
Despite suffering losses due to
overseas acquisitions , the MD
believes in not changing the top
management.
22. COMPANY’S STRATEGIES
“Attracting the right talent and
engaging them for high performance”-
focus of the company.
In order to be placed in the list of best
place to work at, the company implies
various strategies with respect to work
culture, employee benefits and HR
policies.
23. THE VARIOUS STRATEGIES ARE-
•Training and self development activities
to enhance and enrich employee
knowledge and skills.
•Remuneration policy for directors, key
managerial officials and other
employees.
•Aimed in providing each personnel an
environment free from discrimination
and harassment of any kind.
24. CONCLUSION
As Sun Pharma being a leading pharmaceutical
company , it needs to work on its drawbacks to retain
its market share in the global market.
As Sun pharma has acquisition based growth, many
a times the organisation fails to recover back its cost.
So they should have a market research team which
can give them an overall idea regarding the firms
which they plan to acquire.
Sun Pharma is a global leader in the pharmaceuticals
industry but it lack presence in the European market.
So in order to extend its reach the company can tie
up with medium scale pharmaceutical companies of
European market
Product differentiation and innovation also play a